- Home
- TSHA vs HIVE Comparison
TSHA vs HIVE Comparison
Compare TSHA & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- HIVE
- Stock Information
- Founded
- TSHA 2019
- HIVE 1987
- Country
- TSHA United States
- HIVE United States
- Employees
- TSHA N/A
- HIVE N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- HIVE
- Sector
- TSHA Health Care
- HIVE
- Exchange
- TSHA Nasdaq
- HIVE Nasdaq
- Market Cap
- TSHA 1.2B
- HIVE 1.1B
- IPO Year
- TSHA 2020
- HIVE N/A
- Fundamental
- Price
- TSHA $4.87
- HIVE $3.26
- Analyst Decision
- TSHA Strong Buy
- HIVE Strong Buy
- Analyst Count
- TSHA 9
- HIVE 6
- Target Price
- TSHA $10.22
- HIVE $8.33
- AVG Volume (30 Days)
- TSHA 3.9M
- HIVE 21.0M
- Earning Date
- TSHA 11-04-2025
- HIVE 11-17-2025
- Dividend Yield
- TSHA N/A
- HIVE N/A
- EPS Growth
- TSHA N/A
- HIVE N/A
- EPS
- TSHA N/A
- HIVE 0.20
- Revenue
- TSHA $6,310,000.00
- HIVE $193,254,000.00
- Revenue This Year
- TSHA N/A
- HIVE $192.81
- Revenue Next Year
- TSHA N/A
- HIVE $40.30
- P/E Ratio
- TSHA N/A
- HIVE $22.21
- Revenue Growth
- TSHA N/A
- HIVE 57.09
- 52 Week Low
- TSHA $1.05
- HIVE $1.26
- 52 Week High
- TSHA $5.51
- HIVE $7.84
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- HIVE 35.17
- Support Level
- TSHA $3.92
- HIVE $2.74
- Resistance Level
- TSHA $4.34
- HIVE $3.22
- Average True Range (ATR)
- TSHA 0.30
- HIVE 0.35
- MACD
- TSHA 0.06
- HIVE -0.09
- Stochastic Oscillator
- TSHA 98.33
- HIVE 21.52
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.